incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics
Description
R., Plukker, J
![incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics](https://www.enttoday.org/wp-content/uploads/2019/06/ENT_0619_pg22a.png)
Eur J Vasc Endovasc Surg
![incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics](https://diabetesonthenet.com/wp-content/uploads/Morris_Table1.jpg)
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis was published in The BMJ in January 2024
![incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics](https://cdn.rcsb.org/rcsb-pdb/content/639b49f1e543b6038c4fc5e5/gp-1r-signaling-fig1.png)
95% CI 0.07, 0.03), SGLT2is (WMD: 0.05
![incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics](https://i.ytimg.com/vi/f5hhVitTLtU/maxresdefault.jpg)
It mimics a natural hormone our bodies make (GLP-1 analogs), to help regulate blood sugar, curb appetite, and support sustainable weight loss
![incretin mimetics glp 1 agonists A Brief Review of Intended for the Management of Diabetes and Associated Comorbidities[v1] Letter: Association Between Incretin Mimetics](https://img.medscapestatic.com/fullsize/migrated/editorial/dmeflash/2007/7885/images/slide8.gif)